BRAINLIFE Brain Tumor Medical Database

YM155

Home > Database > Treatment > YM155 (Survivin suppressant)

Contents


Medulloblastoma


Nakahara T, Takeuchi M, Kinoyama I, Minematsu T, Shirasuna K, Matsuhisa A, Kita A, Tominaga F, Yamanaka K, Kudoh M, Sasamata M. 
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

Cancer Res. 2007 Sep 1;67(17):8014-21.
  Abstract

 

This website is certified by Health On the Net Foundation. Click to verify. HOMEARCHIVES OF NEURO-ONCOLOGYCURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTS
SERVICES: About BrainLife | Brain Tumor Medical Database | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications

This site complies with the HONcode standard for trustworthy health information: verify here bottom